cro.directory
← Compare landing

Beaufort vs Cisema

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryBeaufortCisema
SummaryBeaufort is a MedTech-specialized CRO offering clinical operations, regulatory strategy, and submission support tailored to device and diagnostic innovations across all therapeutic areas.Cisema supports medical device, IVD, pharmaceutical, and cosmetics companies with NMPA-related product registration, China device clinical studies, and local authorized representative services across China and Asia Pacific. Its offerings also include vigilance and post-market surveillance, quality compliance, and reimbursement market access work.
Services
  • Clinical Trial Services
  • Clinical Operations
  • Regulatory Affairs
  • Clinical Trial Services
  • Clinical Operations
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
  • China NMPA Regulatory Strategy
ModalitiesData not yet provided.Data not yet provided.
IndicationsData not yet provided.Data not yet provided.
Phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Data not yet provided.
Sourcing models
  • Full-Service Outsourcing (FSO)
Data not yet provided.
LocationsData not yet provided.
  • Hong Kong (Headquarters), Hong Kong, Hong Kong
  • Beijing, Beijing, China
  • Tianjin, Tianjin, China
  • Hangzhou, Hangzhou, China
  • Qingdao, Qingdao, China
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Beaufort alternatives · Cisema alternatives

Markdown mirror: /compare/beaufortcro/cisema.md